drugset / Trial / NCT07603518
The Pharmacokinetics of a Hemp-Based Topical Product
Phase 1
Not yet recruiting
20 enrolled
Johns Hopkins University
RTI International · collabSubstance Abuse And Mental Health Administration · collab
NaSingle-groupOpen-labelBasic science
Summary
This study will evaluate the pharmacokinetic effects of acute and chronic dosing of a hemp-based cannabidiol (CBD) topical lotion with low levels of delta-9-tetrahydrocannabinol (THC) in a sanitized and controlled environment.
Timeline
- Start
- 2026-06
- Primary completion
- 2026-08
- Completion
- 2026-09
Indications
No indication recorded.